HMGB1 in health and disease

R Kang, R Chen, Q Zhang, W Hou, S Wu, L Cao… - Molecular aspects of …, 2014 - Elsevier
Complex genetic and physiological variations as well as environmental factors that drive
emergence of chromosomal instability, development of unscheduled cell death, skewed …

Current approaches targeting the wound healing phases to attenuate fibrosis and scarring

A El Ayadi, JW Jay, A Prasai - International journal of molecular sciences, 2020 - mdpi.com
Cutaneous fibrosis results from suboptimal wound healing following significant tissue injury
such as severe burns, trauma, and major surgeries. Pathologic skin fibrosis results in scars …

Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets

V Giorgio, F Prono, F Graziano, V Nobili - BMC pediatrics, 2013 - Springer
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in
children. NAFLD has emerged to be extremely prevalent, and predicted by obesity and male …

Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury

E Arriazu, X Ge, TM Leung, F Magdaleno, A Lopategi… - Gut, 2017 - gut.bmj.com
Objective Liver fibrosis is associated with significant collagen-I deposition largely produced
by activated hepatic stellate cells (HSCs); yet, the link between hepatocyte damage and the …

Host regulators of liver fibrosis during human schistosomiasis

SD Kamdem, R Moyou-Somo, F Brombacher… - Frontiers in …, 2018 - frontiersin.org
Liver fibrosis is a wound-healing process purposely aimed at restoring organ integrity after
severe injury caused by autoimmune reactions, mechanical stress or infections. The …

The transformation in biomarker detection and management of drug‐induced liver injury

RJ Church, PB Watkins - Liver International, 2017 - Wiley Online Library
Drug‐induced liver injury (DILI) is a major concern for patients, care givers and the
pharmaceutical industry. Interpretation of the serum biomarkers routinely used to detect and …

HMGB1: An overview of its roles in the pathogenesis of liver disease

YA Ni, H Chen, H Nie, B Zheng… - Journal of leukocyte …, 2021 - academic.oup.com
High-mobility group box 1 (HMGB1) is an abundant architectural chromosomal protein that
has multiple biologic functions: gene transcription, DNA replication, DNA-damage repair …

Emerging role of high-mobility group box 1 (HMGB1) in liver diseases

R Chen, W Hou, Q Zhang, R Kang, XG Fan, D Tang - Molecular medicine, 2013 - Springer
Damage-associated molecular pattern (DAMP) molecules are essential for the initiation of
innate inflammatory responses to infection and injury. The prototypic DAMP molecule, high …

[PDF][PDF] Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation‐associated liver carcinogenesis in mice

T Pusterla, J Nèmeth, I Stein, L Wiechert, D Knigin… - …, 2013 - Wiley Online Library
The receptor for advanced glycation endproducts (RAGE) is a multiligand receptor and
member of the immunoglobulin superfamily. RAGE is mainly involved in tissue damage and …

Emerging role of HMGB 1 in fibrotic diseases

LC Li, J Gao, J Li - Journal of cellular and molecular medicine, 2014 - Wiley Online Library
High‐mobility group box 1 (HMGB1) is originally identified as a DNA‐binding protein that
functions as a structural co‐factor critical for proper transcriptional regulation in somatic …